Réjeanne Gougeon

Réjeanne Gougeon

Auto-generated profile, based on publicly available information

Réjeanne Gougeon

From the McGill Nutrition and Food Science Centre, McGill University Health Centre–Royal Victoria Hospital, Montreal, Canada

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
RGRéjeanne Gougeon
Réjeanne Gougeon
JMJosé A. Morais
José A. Morais
SCStéphanie Chevalier
Stéphanie Chevalier
SPSandra Pereira
Sandra Pereira
MLMarie Lamarche
Marie Lamarche
EMErrol B. Marliss
Errol B. Marliss
OBJECTIVE—Whole-body protein metabolism is abnormal in suboptimally controlled type 2 diabetes and obesity. We hypothesized that glycemia, insulin resistance, and waist circumference modulate these alterations in type 2 diabetes and, to a lesser extent, in individuals without type 2 diabetes. RESEARCH DESIGN AND METHODS—In 88 lean and obese subjects without and 40 with type 2 diabetes on an inpatient protein-controlled isoenergetic diet for 7 days, whole-body protein turnover was measured using the fed-fasted 60-h oral 15N-glycine method. Nitrogen flux was determined from urinary 15N urea and protein synthesis, breakdown and net balance calculated. Indexes of diabetes control, resting energy expenditure (REE), and body composition were assessed. RESULTS—Higher protein turnover in obese subjects was further increased, and net balance was lower in type 2 diabetes. Waist-to-hip ratio and ln homeostasis model assessment of insulin resistance (HOMA-IR) explained 40% of the variance in flux in type 2 diabetes; fat-free mass and lnHOMA-IR explained 62% in subjects without type 2 diabetes. Overall, fasting glucose explained 16% of the variance in net balance. In type 2 diabetes, net balance correlated negatively with fasting glucose in men and positively with hip circumference in women. CONCLUSIONS—Kinetics of whole-body protein metabolism are elevated, and net balance is diminished in type 2 diabetes, independently of obesity. Elevated flux is associated with greater visceral adiposity, REE, and insulin resistance of glucose. In type 2 diabetic men, these alterations worsened with magnitude of hyperglycemia. In type 2 diabetic women, larger hip circumferences may protect against such alterations. Our findings suggest that dietary protein requirements may be greater in type 2 diabetes to offset a reduced net balance, aggravated as glycemia increases, especially in men.

1 July 2005 in Obesity Research
Verified
Journal Article
Closed access
PDF file
RGRéjeanne Gougeon
Réjeanne Gougeon
KHKathy Harrigan
Kathy Harrigan
JTJean‐François Tremblay
Jean‐François Tremblay
PHPhilip Hedrei
Philip Hedrei
MLMarie Lamarche
Marie Lamarche
JMJosé A. Morais
José A. Morais

1 August 2005 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
SCStéphanie Chevalier
Stéphanie Chevalier
EMErrol B Marliss
Errol B Marliss
JMJosé A Morais
José A Morais
MLMarie Lamarche
Marie Lamarche
RGRéjeanne Gougeon
Réjeanne Gougeon
Background: Obesity is associated with insulin resistance of glucose and lipid metabolism. Objective: We sought to determine the effects of obesity on the insulin sensitivity of protein metabolism. Design: Whole-body [13C]leucine and [3H]glucose kinetics were measured in 9 lean and 10 obese women in the postabsorptive state and during a hyperinsulinemic, euglycemic, isoaminoacidemic clamp. Results: In the postabsorptive state, the leucine endogenous rate of appearance (catabolism), normalized for fat-free mass, was 11% greater and the nonoxidative rate of disappearance (synthesis) was 8% greater in the obese than in the lean women, but net balance was 29% more negative (P < 0.05). Clamp amino acid and glucose infusion rates were significantly lower in the obese women than in the lean women (0.65 ± 0.02 compared with 0.85 ± 0.04 and 5.7 ± 0.3 compared with 9.1 ± 0.5 mg · kg fat-free mass−1 · min−1, respectively; P < 0.0001 for both), and their rates correlated positively (r = 0.635, P = 0.005). During hyperinsulinemia, synthesis was stimulated less and net leucine balance was much lower in the obese women than in the lean women (−0.08 ± 0.06 and 0.30 ± 0.03 μmol · kg fat-free mass−1 · min−1, respectively; P < 0.0001). The percentage change in net leucine balance correlated negatively with all adiposity indexes. Plasma free fatty acids were less suppressed and the respiratory quotient was lower in the obese women than in the lean women. Conclusion: Obese women show a blunted protein anabolic response to hyperinsulinemia that is consistent with resistance to the action of insulin on protein concurrent with that on glucose and lipid metabolism.

1 April 2013 in Canadian Journal of Diabetes
Verified
Journal Article
Closed access
RGRéjeanne Gougeon
Réjeanne Gougeon

26 November 2010 in Diabetologia
Verified
Journal Article
Closed access
PDF file
Maya BassilMaya Bassil
Maya Bassil
EME. B. Marliss
E. B. Marliss
JMJ. A. Morais
J. A. Morais
SPS. Pereira
S. Pereira
SCS. Chevalier
S. Chevalier
RGR. Gougeon
R. Gougeon

26 April 2017 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
CLCherise C. Labonte
Cherise C. Labonte
SFSamaneh Farsijani
Samaneh Farsijani
EMErrol B. Marliss
Errol B. Marliss
RGRéjeanne Gougeon
Réjeanne Gougeon
JMJosé A. Morais
José A. Morais
SCStephanie Chevalier
Stephanie Chevalier
Context: Specific plasma amino acid (AA) profiles including elevated postabsorptive branched-chain amino acids (BCAAs) have been associated with insulin resistance (IR), mostly estimated by homeostatic model assessment. This study assessed the associations of postabsorptive AAs with IR directly measured by insulin-mediated glucose disposal and determined the quantitative value of AAs and conventional IR predictors. Design: Fifty-one healthy, 31 overweight or obese (Ow/Ob), and 52 men and women with type 2 diabetes (T2D) were studied retrospectively. The main outcome measures were the glucose disposal (M/I) index (using 3-[3H]-glucose) during a hyperinsulinemic–euglycemic clamp and whole-body protein turnover (using 1-[13C]-leucine). Results: Compared with healthy participants, M/I was lower in Ow/Ob participants and lowest in those with T2D. BCAAs, glutamate, and lysine were higher in the Ow/Ob and T2D groups than in healthy participants; glycine and threonine were lower. Most AAs were higher in men. Principal component analysis identified component 1 (C1: BCAAs, methionine) and C3 (glycine, threonine, serine). Glutamate, C1, ornithine, lysine, methionine, and tyrosine correlated negatively with M/I; C3 and glycine correlated positively. Waist circumference and sex strongly influenced AA–IR relationships; only glutamate correlated after these factors were controlled for. From regression analysis, waist circumference, fasting glucose, insulin, and free fatty acids (FFAs) negatively predicted 64% of the M/I variance; glutamate added 2% more. In nondiabetic participants, IR was predicted by waist circumference, insulin, and FFAs, without contribution from AAs. Conclusion: Several postabsorptive AAs correlated with IR but added limited predictive value to conventional markers because levels were determined largely by abdominal adiposity. Data suggest a sex-specific regulation of AA metabolism by excess adiposity, particularly the BCAAs, warranting investigation.